European stock futures traded lower early Wednesday in tandem with broad declines in Asian stock benchmarks; the dollar inched higher; Treasury yields edged lower; while oil futures and gold declined.

"The general rule of U.S. healthcare seems to be that everyone is making money except the patient." (Photo subject is a model.) Dear Quentin, I needed to fill a prescription for a 90-day supply of a ...

SpaceX went public less than two weeks ago. Now it just sold one of the biggest AI bond deals yet. SpaceX late Tuesday confirmed pricing for its first bond offering as a public company after upsizing ...

Wall Street's belief in a central-bank safety net misreads the dot-com crash. Alan Greenspan was following rules - not saving portfolios. Alan Greenspan testifying before Congress in 2010. Greenspan, ...

Leveraged ETFs tied to SpaceX aren't for the faint of heart. The excitement around SpaceX shares has quickly faded after they soared in their market debut this month - providing a crushing reminder of ...

The annual rate of PCE inflation is forecast to be 4.1% by FactSet, its highest level since April 2023. Economists expect May to mark this year’s inflation peak, as lower oil prices and easing tariff ...

A previous version of this report included a "Key Point" inaccurately characterizing the effect of SpaceX's share-price decline on Monday. The stock did not close below its IPO price but below its ...

Manufacturing activity in the Richmond Fed's region was flat this month, the reserve bank's monthly survey showed. The survey's composite index was 4 in June, down from 13 in May. Economists polled by ...

"When we asked them what gets in the way, what's the barrier? The workplace was a big barrier - the expectation that they had to be the breadwinner," Schulte said. "Families also expected them to be ...

Lazada, Alibaba's e-commerce platform in Southeast Asia, is cutting 5% of its workforce, according to people familiar with the matter. The company notified the affected employees on Tuesday, some of ...

AbbVie has won expanded European Commission approvals for its blockbuster autoimmune drug Skyrizi and its hepatitis C drug Maviret. AbbVie on Tuesday said Skyrizi is now approved in Europe for ...

Provided by Dow Jones Jun 23, 2026, 4:14:00 PM ...